dichlorphenamide has been researched along with Andersen Cardiodysrhythmic Periodic Paralysis in 1 studies
Dichlorphenamide: A carbonic anhydrase inhibitor that is used in the treatment of glaucoma.
diclofenamide : A sulfonamide that is benzene-1,3-disulfonamide in which the hydrogens at positions 4 and 5 are substituted by chlorine. An oral carbonic anhydrase inhibitor, it partially suppresses the secretion (inflow) of aqueous humor in the eye and so reduces intraocular pressure. It is used for the treatment of glaucoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, A | 1 |
| Iyadurai, S | 1 |
| Roggenbuck, J | 1 |
| LoRusso, S | 1 |
1 review available for dichlorphenamide and Andersen Cardiodysrhythmic Periodic Paralysis
| Article | Year |
|---|---|
Marked reduction in paralytic attacks in a patient with Andersen-Tawil syndrome switched from acetazolamide to dichlorphenamide.
Topics: Acetazolamide; Andersen Syndrome; Carbonic Anhydrase Inhibitors; Dichlorphenamide; Female; Humans; M | 2021 |